产品订购信息：
英文名称  Anti-NDUFS7 

中文名称   线粒体复合物NDUFS7蛋白抗体规格 

别    名  CI 20; CI-20kD; Complex I 20kDa subunit; Complex I mitochondrial respiratory chain 20 KD subunit; Complex I-20kD; MGC120002; MY017; NADH coenzyme Q reductase; NADH dehydrogenase (ubiquinone) Fe S protein 7 20kDa (NADH coenzyme Q reductase); NADH dehydrogenase (ubiquinone) FeS protein 7, 20kDa (NADHcoenzyme Q reductase); NADH dehydrogenase (ubiquinone) FeS protein7, 20kDa (NADHcoenzyme Q reductase); NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial; NADH-ubiquinone oxidoreductase 20 kDa subunit; NADH:ubiquinone oxidoreductase PSST subunit; NADHcoenzyme Q reductase; Ndufs7; NDUS7_HUMAN; PSST; PSST subunit.

浓    度   1mg/1ml

规 格  0.2ml/200μg

抗体来源   Rabbit

克隆类型   polyclonal

交叉反应   Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse 

产品类型   一抗  

研究领域     细胞生物 神经生物学 信号转导

蛋白分子量  predicted molecular weight: 20kDa

性    状   Lyophilized or Liquid

免 疫 原 KLH conjugated synthetic peptide derived from human NDUFS7 (101-160aa) 

亚    型   IgG

纯化方法   affinity purified by Protein A

储 存 液   Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4

线粒体复合物NDUFS7蛋白抗体规格 产品应用    WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500

（石蜡切片需做抗原修复） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存条件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

产品介绍 Located in the mitochondrial inner membrane, mitochondrial complex I is the first and largest enzyme in the electron transport chain of oxidative phosphorylation. By oxidizing NADH that is produced in the Krebs cycle, this complex utilizes the two electrons to reduce ubiquinone to ubiquinol, thereby initiating the passage of electrons to successive complexes and ultimately leading to the reduction of oxygen to water. Mitochondrial complex I consists of over 40 subunits and is of considerable clinical interest since defects in any of the subunits can lead to various myopathies and neuropathies. As a subunit of mitochondrial complex I, NDUFS7 (NADH dehydrogenase [ubiquinone] iron-sulfur protein 7), also designated NADH-ubiquinone oxidoreductase 20 kDa subunit, is a 213 amino acid protein that is suggested to be required for catalytic activity. Defects in the gene encoding NDUFS7 are the cause of Leigh syndrome, a severe neurological disorder that is characterized by bilaterally symmetrical necrotic lesions in subcortical brain regions.

Function : Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) that is believed to belong to the minimal assembly required for catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone.Subunit : Complex I is composed of 45 different subunits This is a component of the iron-sulfur (IP) fragment of the enzyme.Subcellular Location : Mitochondrion.DISEASE : Defects in NDUFS7 are a cause of Leigh syndrome (LS) [MIM:256000]. LS is a severe neurological disorder characterized by bilaterally symmetrical necrotic lesions in subcortical brain regions. Defects in NDUFS7 are a cause of mitochondrial complex I deficiency (MT-C1D) [MIM:252010]. A disorder of the mitochondrial respiratory chain that causes a wide range of clinical disorders, from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease.Similarity : Belongs to the complex I 20 kDa subunit family.Database links : UniProtKB/Swiss-Prot: O75251.3

Anti-RANK/TNFRSF11A/CD265/FITC 荧光素标记核转录因子NF-κB受体抗体IgGMulti-class antibodies规格： 0.2ml

Rabbit Anti-rat IgG/HRP 辣根过氧化物酶标记兔抗大鼠IgGMulti-class antibodies规格： 0.1ml

嗜铬粒素A抗体 Anti-CGA 0.2ml

Rabbit Anti-horse IgM/Alexa Fluor 350 Alexa Fluor 350标记的兔抗马IgM 0.1ml

Fibulin 1 英文名称： “衰老关键蛋白”抗体 0.2ml

Rhesus antibody Rh PKC beta 1/2 蛋白激酶C beta 1/2抗体 规格 0.1ml

Rabbit Anti-rat IgG/HRP 辣根过氧化物酶标记兔抗大鼠IgGMulti-class antibodies规格： 0.1ml

HPV16-E7/E7 protein(Human papillomavirus type 16) 人类状瘤病毒16抗原Multi-class antibodies规格： 0.5mg

Anti-ABCF1 ATP结合盒蛋白家族GCN20F家族1抗体Multi-class antibodies规格： 0.2ml

Rhesus antibody Rh Phospho-CHK2 (Thr387) 磷酸化细胞周期检测点激酶2抗体 规格 0.1ml

兔抗大鼠IgG血清 0.5ml 国产

WISP2 英文名称： 结缔组织生长因子样蛋白抗体 0.2ml

Phospho-DOK2 (Tyr299) 英文名称： 磷酸化D酪酸激酶衰减蛋白2抗体 0.1ml

Anti-ABCF1 ATP结合盒蛋白家族GCN20F家族1抗体Multi-class antibodies规格： 0.2ml

8-OHdG 英文名称： 8-羟基脱氧鸟苷抗体 0.1ml

phospho-Eph receptor B1 (Tyr928) 英文名称： 磷酸化酪酸蛋白激酶受体B1抗体 0.1ml

凝血调节蛋白抗体 Anti-CD141 0.1ml

Anti-Influenza A Virus H1/HRP 辣根过氧化物酶标记羊抗季节性A型病毒H1抗体IgGMulti-class antibodies规格： 0.2ml

Rhesus antibody Rh Phospho-HDAC3 (Ser424) 磷酸化组蛋白去乙酰化酶3抗体 规格 0.1ml

GHRP-6 Acetate peptide(Growth hormone-releasing peptides 6) 醋酸促生长激素释放肽6Multi-class antibodies规格： 1g

KAgar

HE琼脂 从其它肠道革兰氏阴性菌中分离沙门氏菌和志贺氏菌 500g incubation media HE琼脂 从其它肠道革兰氏阴性菌中分离沙门氏菌和志贺氏菌 500g

白黄链霉菌 支/瓶

马铃薯葡萄糖琼脂(PDA)300ml/袋*霉菌酵母菌计数

Letheen琼脂 250g 用于化妆品中微生物检测

抗生素检定培养基7号250g用于头孢噻肟灯的效价测定

抗生素检定培养基2号(pH 6.5-6.6) 250(g) incubation media 抗生素检定培养基2号(pH 6.5-6.6) 250(g)

1%聚山梨酯80-玉米琼脂培养基 100g 用于白色念珠菌芽管试验的培养

胰蛋白胨250培养基原材料，提供细菌生长氮源，含色氨酸incubationmedia胰蛋白胨250培养基原材料，提供细菌生长氮源，含色氨酸

疱肉培养基(液体)(试管) 1支 用于肉毒梭菌及厌氧梭状芽孢杆菌的检验(GB标准)。

线粒体复合物NDUFS7蛋白抗体规格 酵母浸膏  规格：  25Kg  用途：  培养基原材料

酵母浸膏  规格：  5Kg  用途：  培养基原材料

酵母浸膏  规格：  500g  用途：  培养基原材料

多价蛋白胨  规格：  500g  用途：  培养基原材料

抗体的生物素化标记实验要点：

1. 线粒体复合物NDUFS7蛋白抗体规格 如在反应混合液中有叠氮钠或游离氨基存在,会抑制标记反应。因此,蛋白质在反应前要对 0.1mol/L碳酸氢钠缓冲液或0.5mol/L硼酸缓冲液充分透析；

2.所用的NHSB及待生物素化蛋白质之间的分子比按蛋白质表面的ε-氨基的密度会有所不同,选择不当则影响标记的效率,应先用几个不同的分子比来筛选最适条件；

3.用NHSB量过量也是不利的,抗原的结合位点可能因此被封闭,导致抗体失活；

4.由于抗体的氨基不易接近可能造成生物素化不足,此时可加入去污剂如 Triton x-100, Tween20等；

5.当游离ε-氨基(赖氨酸残基的氨基)存在于抗体的抗原结合位点时,或位于酶的催化位点时,生物素化会降低或损伤抗体蛋白的结合力或活性；

6.生物素还可能与不同的功能基团,如羰基、氨基、巯基、异咪唑基及*基,也可与糖基共价结合；

7.交联反应后,应充分透析,否则,残余的生物素会对生物素化抗体与亲和素的结合产生竞争作用；

8.在细胞的荧光标记实验中,中和亲和素的本底低,但由于链霉亲和素含有少量正电荷,故对某些细胞可导致高本底。

抗体的鉴定：

1）线粒体复合物NDUFS7蛋白抗体规格 抗体的效价鉴定：不管是用于诊断还是用于,制备抗体的目的都是要求较高效价。不同的抗原制备的抗体,要求的效价不一。鉴定效价的方法很多,包括有试管凝集反应,琼脂扩散试验,酶联免疫吸附试验等。常用的抗原所制备的抗体一般都有约成的鉴定效价的方法,以资比较。如制备抗抗体的效价,一般就采用琼脂扩散试验来鉴定。

2）抗体的特异性鉴定：抗体的特异性是指与相应抗原或近似抗原物质的识别能力。抗体的特异性高,它的识别能力就强。衡量特异性通常以交叉反应率来表示。交叉反应率可用竞争抑制试验测定。以不同浓度抗原和近似抗原分别做竞争抑制曲线,计算各自的结合率,求出各自在IC50时的浓度,并按公式计算交叉反应率。 

如果所用抗原浓度IC50浓度为pg/管,而一些近似抗原物质的IC50浓度几乎是无穷大时,表示这一抗血清与其他抗原物质的交叉反应率近似为0,即该血清的特异性较好。

3）抗体亲和力：是指抗体和抗原结合的牢固程度。亲和力的高低是由抗原分子的大小,抗体分子的结合位点与抗原决定簇之间立体构型的合适度决定的。有助于维持抗原抗体复合物稳定的分子间力有氢键,疏水键,侧链相反电荷基因的库仑力,范德华力和空间斥力。亲和力常以亲和常数K表示,K的单位是L/mol。抗体亲和力的测定对抗体的筛选,确定抗体的用途,验证抗体的均一性等均有重要意义。